{"groups":[{"description":"CONDITIONING: Patients receive busulfan IV over 3 hours on days -6 to -3, melphalan IV over 20 minutes on day -2, and bortezomib IV over 3-5 seconds on days -6, -3, 1, and 4.\n\nTRANSPLANT: Patients undergo autologous PBSCT on day 0.\n\nBusulfan: Given IV\n\nMelphalan: Given IV\n\nBortezomib: Given IV\n\nAutologous Hematopoietic Stem Cell Transplantation: Undergo autologous PBSCT\n\nPeripheral Blood Stem Cell Transplantation: Undergo autologous PBSCT","id":"FG000","title":"Treatment (Busulfan, Melphalan, Bortezomib, Autologous PBSCT)"}],"periods":[{"milestones":[{"achievements":[{"groupId":"FG000","numSubjects":"19"}],"type":"STARTED"},{"achievements":[{"groupId":"FG000","numSubjects":"18"}],"type":"COMPLETED"},{"achievements":[{"groupId":"FG000","numSubjects":"1"}],"type":"NOT COMPLETED"}],"title":"Overall Study"}]}